Delivery Order SPE2DX22D0019-SPE2D826FCF27
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,785.54 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract vehicle with a ceiling value of $999,999,999.00 that runs through December 2026. The delivery order is scheduled for completion by January 7, 2026, with performance occurring at the company's corporate office...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,097.32 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order operates under firm fixed pricing and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,296.75 by the Defense Logistics Agency's Medical Supply Chain on July 16, 2025, with an ultimate completion date of July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $8,771.85 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The work...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,109.36 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCF27Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/5/26 |